home / stock / acet / acet short
Short Information | Adicet Bio Inc. (NASDAQ:ACET)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 3,066,070 |
Total Actual Volume | 25,288,384 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 153,304 |
Average Short Percentage | 17.02% |
Is there a ACET Short Squeeze or Breakout about to happen?
See the ACET Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-05-2024 | $1.1 | $1.07 | $1.13 | $1.07 | 721,077 | 77,036 | 10.68% |
07-03-2024 | $1.1 | $1.09 | $1.12 | $1.05 | 830,888 | 166,488 | 20.04% |
07-02-2024 | $1.16 | $1.1 | $1.16 | $1.09 | 1,185,781 | 246,219 | 20.76% |
07-01-2024 | $1.22 | $1.15 | $1.24 | $1.15 | 1,658,117 | 254,285 | 15.34% |
06-28-2024 | $1.34 | $1.21 | $1.34 | $1.21 | 8,136,938 | 326,862 | 4.02% |
06-27-2024 | $1.34 | $1.34 | $1.38 | $1.27 | 626,753 | 121,232 | 19.34% |
06-26-2024 | $1.44 | $1.34 | $1.475 | $1.32 | 1,003,183 | 217,174 | 21.65% |
06-25-2024 | $1.47 | $1.47 | $1.5 | $1.41 | 964,281 | 173,962 | 18.04% |
06-24-2024 | $1.4 | $1.5 | $1.515 | $1.3997 | 3,262,786 | 248,091 | 7.6% |
06-21-2024 | $1.36 | $1.37 | $1.4 | $1.36 | 534,607 | 59,761 | 11.18% |
06-20-2024 | $1.34 | $1.36 | $1.4 | $1.33 | 476,022 | 72,146 | 15.16% |
06-18-2024 | $1.3 | $1.34 | $1.38 | $1.3 | 435,229 | 81,703 | 18.77% |
06-17-2024 | $1.34 | $1.32 | $1.34 | $1.3 | 612,274 | 138,168 | 22.57% |
06-14-2024 | $1.46 | $1.35 | $1.48 | $1.34 | 495,902 | 126,466 | 25.5% |
06-13-2024 | $1.42 | $1.45 | $1.49 | $1.36 | 578,127 | 114,181 | 19.75% |
06-12-2024 | $1.32 | $1.4 | $1.43 | $1.3 | 721,083 | 119,395 | 16.56% |
06-11-2024 | $1.28 | $1.29 | $1.31 | $1.245 | 920,179 | 105,826 | 11.5% |
06-10-2024 | $1.37 | $1.31 | $1.38 | $1.27 | 558,322 | 146,674 | 26.27% |
06-07-2024 | $1.4 | $1.35 | $1.4 | $1.322 | 665,463 | 142,058 | 21.35% |
06-06-2024 | $1.44 | $1.4 | $1.5 | $1.38 | 901,372 | 128,343 | 14.24% |
News, Short Squeeze, Breakout and More Instantly...
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to ADI-270 for the potentia...
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to ADI-001 for the potentia...
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that Chen Schor, President and Chief Executive Officer, will participate in a fireside chat at the Jefferi...